Care/of Safety, Regulation & Compliance: An Independent Review

What Regulatory Framework Actually Governs Care/of?

Care/of sells dietary supplements, not drugs. That distinction is the single most important fact for any consumer evaluating the brand's safety posture.

Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA does not evaluate or approve a supplement for safety or efficacy before it reaches store shelves. The manufacturer is legally responsible for ensuring its products are safe and that label claims are truthful. The FDA acts after a problem is reported, not before.

DSHEA vs. Drug Approval: A Real Difference in Oversight

For a prescription drug, a sponsor must submit clinical data proving safety and efficacy before the FDA grants approval. That process can take more than ten years and cost over a billion dollars. For a supplement like a vitamin D softgel or an ashwagandha capsule, the manufacturer files a New Dietary Ingredient (NDI) notification if the ingredient was not marketed before October 15, 1994, but no affirmative FDA approval is required. The FDA's own consumer guidance explains this gap clearly: "It's the company's responsibility to make sure its products are safe." (FDA, 2023)

Care/of operates entirely within this framework. The brand markets vitamins, minerals, adaptogens, protein powders, and other ingredients that fall under DSHEA, not any prescription drug category.

Current Good Manufacturing Practices (cGMP) Compliance

The FDA does require all dietary supplement manufacturers to follow 21 CFR Part 111, the Current Good Manufacturing Practice (cGMP) regulations for dietary supplements. These regulations cover identity testing of raw ingredients, contamination controls, batch record-keeping, and finished-product testing. (FDA, 21 CFR Part 111)

Care/of states it manufactures in cGMP-certified facilities. The brand's website references internal quality testing and third-party audits, but it does not publicly list the name of its primary manufacturer or provide a searchable batch-level certificate of analysis (COA) database. That absence is a meaningful transparency gap compared to brands like Thorne, which publishes COAs on request, or Pure Encapsulations, whose manufacturing facility holds NSF International certification.

Does Care/of Use Third-Party Testing?

Care/of's marketing asserts that all products are third-party tested. The actual depth and type of that testing deserves closer examination.

What "Third-Party Tested" Can Mean

Third-party testing exists on a spectrum. At the lower end, a brand may send a single lot of a finished product to an independent lab to confirm it contains what the label states and is free of heavy metals or microbial contamination. That is legitimate but limited. At the higher end, organizations like NSF International, USP (United States Pharmacopeia), and Informed Sport run ongoing, randomized audits of manufacturing facilities and individual products, publishing results in publicly searchable databases.

NSF's Certified for Sport program, for example, tests for approximately 270 substances banned by major athletic organizations, verifies label claims, and audits manufacturing sites. (NSF International, Certified for Sport)

USP Verified supplements must meet USP's standards for ingredient identity, potency, purity (including limits on contaminants), and dissolution. (USP, 2024)

As of July 2025, Care/of products do not carry the NSF Certified for Sport mark or USP Verified seal on the brand's main supplement lines. The brand does reference third-party testing but does not specify which accredited body performed the testing for each product, nor does it link to individual COAs from the product listing pages.

Why This Matters for Consumers

A 2023 review published in JAMA Network Open analyzed 57 herbal and botanical supplements sold online; 20% did not contain the listed botanical at the claimed concentration, and 5 products contained unlisted active ingredients. (Cohen PA et al., JAMA Network Open, 2023) That study did not test Care/of products specifically, but it illustrates why independent certification, not just self-reported testing, matters for the supplement category broadly.

Consumers with performance requirements (competitive athletes subject to anti-doping rules) or clinical needs (supplementing a documented deficiency confirmed by bloodwork) should prioritize products carrying NSF Certified for Sport or USP Verified marks, because those programs provide publicly verifiable, ongoing batch-level accountability.

Is Care/of Legitimate as a Company?

Yes. Care/of is a real, operating business with documented corporate structure, a regulatory history free of FDA warning letters, and meaningful institutional backing.

Corporate Ownership and Financial Standing

Bayer AG, one of the world's largest pharmaceutical and life sciences companies, acquired Care/of in 2020 for approximately $225 million. Bayer disclosed the acquisition in its 2020 annual report. Operating under a major pharmaceutical parent does not by itself guarantee product quality, but it does mean Care/of is subject to Bayer's internal quality management systems and legal compliance infrastructure, which are substantially more rigorous than those available to a small, independent supplement startup.

FDA Enforcement Record

A search of FDA's publicly available warning letter database shows no warning letters issued to Care/of or its manufacturing partners as of July 2025. (FDA Warning Letters Database) That is a meaningful baseline. The FDA does not inspect every facility every year, so a clean enforcement record reflects absence of known violations, not necessarily a comprehensive audit.

The HealthRX editorial team developed the following four-point framework for evaluating any personalized supplement brand's compliance posture. We call it the CTIA check:

1. Certification: Does the product carry an NSF, USP, or Informed Sport mark that is independently searchable?
2. Transparency: Does the brand publish COAs, facility names, and manufacturer audit reports?
3. Ingredient disclosure: Are all ingredient forms (e.g., methylcobalamin vs. Cyanocobalamin for B12) and exact doses listed per serving?
4. Adverse event reporting: Does the brand have a documented process for collecting and submitting serious adverse event reports to the FDA, as required under the Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006?

Applied to Care/of: the brand scores adequately on items 3 and 4, partially on item 1 (third-party testing claimed but not certified by a named accredited body on most SKUs), and weakly on item 2 (no publicly accessible COA library).

Care/of Personalized Supplements: How the Quiz Works

Care/of's central product is a personalized supplement recommendation driven by an online quiz covering diet, lifestyle, health goals, and self-reported symptoms.

The Algorithm's Clinical Limitations

The quiz takes roughly five minutes. It asks about sleep quality, stress levels, dietary preferences, and specific health goals like "heart health" or "focus." Based on responses, Care/of recommends a bundle of supplements along with brief summaries of supporting evidence for each ingredient.

This model has value as a consumer education tool. A person who has never considered their omega-3 intake or vitamin D status may learn something useful. The limitation is that quiz-based recommendations cannot replicate a clinical assessment. Blood levels of 25-hydroxyvitamin D, for example, are the accepted standard for identifying vitamin D deficiency. The Endocrine Society defines vitamin D deficiency as a serum 25(OH)D level below 20 ng/mL and recommends supplementation doses based on measured deficiency severity, not self-reported fatigue. (Holick MF et al., Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, 2011)

A quiz cannot determine whether a person's fatigue reflects a vitamin D deficiency, subclinical hypothyroidism, iron deficiency anemia, or simply poor sleep hygiene. Supplementing without knowing the underlying cause may delay appropriate diagnosis.

Ingredient Evidence Quality

Care/of publishes short evidence summaries on its website for each ingredient, graded by a star system. Some ingredients in the lineup, like omega-3 fatty acids and vitamin D, have substantial evidence bases. The American Heart Association notes that omega-3 supplementation (eicosapentaenoic acid and docosahexaenoic acid) may reduce triglycerides at doses of 2 to 4 grams per day. (American Heart Association, Fish and Omega-3 Fatty Acids, 2023)

Other offerings, such as adaptogens like ashwagandha for stress, have more limited clinical evidence. A 2021 systematic review in the Journal of Ethnopharmacology (N=491 across five RCTs) found ashwagandha extract reduced self-reported stress and anxiety scores versus placebo, but effect sizes were modest and trial durations ranged from only 8 to 12 weeks. (Pratte MA et al., J Ethnopharmacol, 2014; and Gopukumar K et al., J Ethnopharmacol, 2021) Consumers should understand that "evidence-backed" as used by supplement brands does not necessarily mean the evidence meets the bar required for drug approval.

Care/of vs. Alternatives: A Comparative Look

Choosing between Care/of and competing personalized supplement brands involves weighing personalization features, third-party certification, price, and ingredient quality.

Thorne Research

Thorne manufactures supplements in an NSF International-certified facility and submits specific products for NSF Certified for Sport review. Thorne also provides COAs on request and is one of the few supplement brands that has sponsored and participated in human clinical research on its own formulations. Price per month is typically higher than Care/of, often $60 to $120 for a comparable stack, but the audit trail is more transparent.

Ritual

Ritual targets similar demographic groups as Care/of, emphasizing minimalist formulations and supply chain transparency. Ritual publishes the supplier and country of origin for every ingredient on its website and has submitted its women's multivitamin to third-party testing. The brand does not carry a blanket NSF or USP mark but scores well on transparency metric 2 in the CTIA framework above.

Pure Encapsulations

Pure Encapsulations is aimed more at clinical practitioners than direct-to-consumer sales, but products are available without a prescription. Its manufacturing facility is NSF certified, and the brand avoids most common excipients. It lacks Care/of's personalization quiz feature but offers cleaner audit documentation.

Head-to-Head on Key Safety Metrics

| Brand | NSF/USP Mark | Public COA | cGMP Certified | Quiz-Based Personalization | |---|---|---|---|---| | Care/of | Not on main lines | No public database | Stated | Yes | | Thorne | NSF (select products) | On request | Yes (NSF facility) | Partial (intake form) | | Ritual | No blanket mark | Partial (ingredient sourcing) | Stated | No | | Pure Encapsulations | NSF (facility) | On request | Yes (NSF facility) | No |

No brand in this category offers the pre-market approval rigor of an FDA-approved pharmaceutical. The differences are in the depth of post-production verification.

Potential Interactions and Clinical Cautions

Supplements are not inert. Because Care/of recommends multiple products simultaneously, the interaction burden across a full "pack" is a real consideration.

Specific Combinations to Flag with a Clinician

High-dose vitamin E (above 400 IU per day) may increase bleeding risk in patients taking warfarin or other anticoagulants. (NIH Office of Dietary Supplements, Vitamin E Fact Sheet, 2023) Iron supplementation can reduce absorption of levothyroxine when taken concurrently. Fish oil at doses above 3 grams per day may have additive antiplatelet effects with aspirin or clopidogrel. The NIH Office of Dietary Supplements maintains a Dietary Supplement Label Database and interaction checker that consumers and clinicians can use to assess individual product combinations. (NIH DSLD)

Care/of's quiz does ask about current medications in a limited way, but it is not a substitute for a pharmacist's or physician's review of the full medication and supplement list.

Populations Who Need Extra Caution

Pregnant and breastfeeding individuals should not self-select supplements without obstetric guidance. The American College of Obstetricians and Gynecologists states that prenatal vitamin selection, particularly folate form and dose, should be individualized. (ACOG Practice Bulletin, 2022) Individuals with chronic kidney disease face real risk from excess vitamin D, calcium, and potassium supplementation. Those on immunosuppressive therapy post-transplant should avoid elderberry and several other immune-modulating botanicals without explicit clinician approval.

What Care/of Does Not Offer

Care/of does not prescribe medications. The service does not offer testosterone replacement therapy, GLP-1 receptor agonists, thyroid hormone, or any FDA-regulated drug. This is worth stating clearly because some telehealth supplement brands have expanded into prescription services. Care/of, as of July 2025, remains a supplement-only brand. Consumers seeking clinically supervised hormone optimization, weight-loss pharmacotherapy, or treatment for diagnosed deficiencies should use a licensed telemedicine provider with prescribing authority.